The company was founded in April 2003 and is a national high-tech enterprise specializing in research, production and marketing of peptide drugs. The company was listed on the Shenzhen Stock Exchange in 2011 and is the earliest listed peptide pharmaceutical company in China. The company's main business is the production and sale of peptide APIs. The company's main products include peptide preparations, peptide raw materials, customer-specific peptides, cosmetic peptides, solid pharmaceutical preparations, medical devices, peptide skin care products, health products, etc. Company Honors: National High-tech Enterprise, National Advanced Technology Industrialization Demonstration Project, 2010 China's Top 200 Potential Enterprises, etc.
No Data
No Data